Incidence of pediatric, adolescent and young adult head and neck melanoma is up 51 percent
Head and neck melanoma among pediatric, adolescent and young adult populations in the United States and Canada increased by 51.1% from 1995 to 2014.
Read moreLung Cancer
'Dietary' vulnerability found in cancer cells with mutated spliceosomes
A research team has discovered a metabolic vulnerability in multiple types of cancer cells that bear a common genetic mutation affecting cellular machines called spliceosomes.
Read moreVaping-associated lung injury may be caused by toxic chemical fumes, study finds
Research into the pathology of vaping-associated lung injury is in its early stages, but a study finds that lung injuries from vaping most likely are caused by direct toxicity or tissue damage from noxious chemical fumes.
Read moreCancer data provide insights into occurrence, overdiagnosis, and treatment advances
Investigators analyzed 40 years of cancer burden data and examined patterns of incidence and mortality for various cancers, finding examples for which incidence and mortality moved in concert and examples where discordance in incidence and mortality indicate that overdiagnosis may be at play.
Read moreAspirin may halve air pollution harms
A new study is the first to report evidence that nonsteroidal anti-inflammatory drugs (NSAIDs) like aspirin may lessen the adverse effects of air pollution exposure on lung function. The researchers found that the use of any NSAID nearly halved of the effect of PM on lung function, with the association consistent across all four weekly air pollution measurements from same-day to 28 days prior to the lung function test.
Read morePatient cancer cells reliably grow on new 3D scaffold, showing promise for precision medicine
A new 3D structure for growing cell cultures could enable doctors to test medications on model tumors grown from a patient's own cells, according to a team of engineers and cancer researchers.
Read morePioneering red light-activated anti-tumor prodrug reduces side effects
Phorbiplatin is a new anti-cancer prodrug that can be controllably activated by red light. With its unique 'on-site' activation characteristic, this new prodrug can effectively kill cancer cells and minimize damage to normal tissues.
Read moreA new route to blocking children's bone cancer
A study in mice showed that reducing a particular hormone signal keeps the cancer from growing and spreading.
Read moreEngineered T cells may be harnessed to kill solid tumor cells
A new study finds that a form of immunotherapy used to treat the blood cancer leukemia may be effective in treating other kinds of cancer as well.
Read moreDecades-long drop in breast cancer death rate continues
A decades-long decline in the breast cancer death rate continues, but has begun to slow in recent years.
Read more